Pharmacological treatment of type 2 diabetes in Saudi Arabia: A consensus statement from the Saudi Society of Endocrinology and Metabolism (SSEM)
- DOI
- 10.1016/j.dsx.2021.04.003
- Published
- 2021-05
- Container
- Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.dsx.2021.04.003,
title = {Pharmacological treatment of type 2 diabetes in Saudi Arabia: A consensus statement from the Saudi Society of Endocrinology and Metabolism (SSEM)},
author = {Mohammed E. Al-Sofiani and Mohammed A. Batais and Essa Aldhafiri and Aus Alzaid},
year = {2021},
journal = {Diabetes \& Metabolic Syndrome: Clinical Research \& Reviews},
doi = {10.1016/j.dsx.2021.04.003},
url = {https://doi.org/10.1016/j.dsx.2021.04.003}
}RIS
TY - JOUR TI - Pharmacological treatment of type 2 diabetes in Saudi Arabia: A consensus statement from the Saudi Society of Endocrinology and Metabolism (SSEM) AU - Mohammed E. Al-Sofiani AU - Mohammed A. Batais AU - Essa Aldhafiri AU - Aus Alzaid PY - 2021 JO - Diabetes & Metabolic Syndrome: Clinical Research & Reviews DO - 10.1016/j.dsx.2021.04.003 UR - https://doi.org/10.1016/j.dsx.2021.04.003 ER -
APA
Al-Sofiani, M. E., Batais, M. A., Aldhafiri, E., & Alzaid, A. (2021). Pharmacological treatment of type 2 diabetes in Saudi Arabia: A consensus statement from the Saudi Society of Endocrinology and Metabolism (SSEM). Diabetes & Metabolic Syndrome: Clinical Research & Reviews. https://doi.org/10.1016/j.dsx.2021.04.003
Source records
- crossref · retrieved 2026-09-27T03:45:21.294Z